Search
for

    Sort by

    Research 151–180 of 154

    1. Cooling-mediated protection from chemotherapy drug-induced cytotoxicity in human keratinocytes by inhibition of cellular drug uptake PLoS ONE · 2020 · 11 citations
    2. The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction Fertility and Sterility · 2021 · 8 citations
    3. Molecular stratification of the human fetal vaginal epithelium by spatial transcriptome analysis Acta Biochimica et Biophysica Sinica · 2024 · 1 citations
    4. AcD : A Novel Bioactive Polymer Scaffold of Adipose‐Derived Stem Cells Combining With Decellularized Extracellular Matrix in Tissue Engineering Journal of Polymer Science · 2025
    5. Expression of AR, 5αR1 and 5αR2 in bladder urothelial carcinoma and relationship to clinicopathological factors Life sciences · 2017 · 13 citations
    6. 5α-reductase inhibitors impact prognosis of urothelial carcinoma BMC Cancer · 2020 · 23 citations
    7. Polypoid Cystitis and Bilateral Hydronephrosis Mimicking Urothelial Carcinoma Journal of endourology case reports · 2019 · 3 citations
    8. Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive? Clinical genitourinary cancer · 2019 · 9 citations
    9. Bladder Cancer: The Hormonal Dependence Enigma and a New Hormonal Player Indian Journal of Surgery · 2014 · 3 citations
    10. Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system Frontiers in Medicine · 2026
    11. Neoadjuvant therapy with Disitamab vedotin in treating muscle-invasive bladder cancer: A case report Heliyon · 2023 · 1 citations
    12. Forum Pharmaceutical Medicine · 2012
    13. The Molecular Pathogenesis of Trichilemmal Carcinoma Research Square (Research Square) · 2020
    14. The Molecular Pathogenesis of Trichilemmal Carcinoma Research Square (Research Square) · 2020
    15. 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence Bladder cancer · 2020 · 3 citations
    16. The molecular pathogenesis of Trichilemmal carcinoma BMC Cancer · 2020 · 19 citations
    17. Kinetic topographical heterogeneity in follicular thyroid neoplasms and growth patterns Histopathology · 2007 · 8 citations
    18. Successful in situ 5-aminolevulinic acid photodynamic therapy in a 53-year-old female with cutaneous squamous cell carcinoma Journal of Zhejiang University SCIENCE B · 2025 · 1 citations
    19. Somatic Mutations in Normal Tissues: New Perspectives on Early Carcinogenesis Annual Review of Cancer Biology · 2023 · 13 citations
    20. Toward a Unifying Hypothesis for Redesigned Lipid Catabolism as a Clinical Target in Advanced, Treatment-Resistant Carcinomas International journal of molecular sciences · 2023
    21. A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro Drug Design Development and Therapy · 2015 · 12 citations
    22. Significance of stress keratin expression in normal and diseased epithelia iScience · 2024 · 47 citations
    23. The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development The EMBO Journal · 2007 · 125 citations
    24. RASopathic Skin Eruptions during Vemurafenib Therapy PLoS ONE · 2013 · 82 citations
    25. Disruption of tubular Flcn expression as a mouse model for renal tumor induction Kidney International · 2015 · 29 citations
    26. The human keratins: biology and pathology Histochemistry and Cell Biology · 2008 · 1398 citations
    27. Patterns of desmocollin synthesis in human epithelia: immunolocalization of desmocollins 1 and 3 in special epithelia and in cultured cells. PubMed · 1996 · 96 citations
    28. Metformin and Malignant Tumors: Not Over the Hill Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · 2021 · 14 citations
    29. The relationship between keratin 18 and epithelial-derived tumors: as a diagnostic marker, prognostic marker, and its role in tumorigenesis Frontiers in Oncology · 2024
    30. Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors The Journal of Urology · 2018 · 20 citations